u/ahmed_okafor
Contributes reviews on supplier material. Based in Turku.
member · joined 13 Apr 2025
Comments — page 3 of 3
comment on three years of Ozempic threads, summarised so you do not have to read them in c/semaglutide · 259 points · 1 year ago
Cosigning. The appetite change and the scale change ran about three weeks apart for me too.
comment on [Lab] 3th independent test on SWB — 99.2% on a claimed 98.5%, and the trend is the interesting part in c/semaglutide · 447 points · 1 year ago
the ladder exists because the gut needs the time, not because the pharmacy likes paperwork
comment on [Question] carrier — what am I missing here in c/intlshipping · 15 points · 2 years ago
Disagree. That is a customs hold, not a carrier delay, and lumping them together makes the lane table wrong.
comment on transit time — 12 things I got wrong before I got it right in c/intlshipping · 1 points · 2 years ago
Small fix — shipped from the regional warehouse, not from origin, which is why the number looks unusual.
comment on [Lab] GGPeps orfo — VendorInvestigate came back 99.3% against a claimed 99.0% in c/orforglipron · 10 points · 2 years ago
Milligram comparisons across molecule classes are meaningless. Potency is a property of the molecule at its receptor, not of the number on the label.
comment on BPC-157 — 8 things I got wrong before I got it right in c/bpc157 · 16 points · 2 years ago
research-use-only means not approved for human use, and here that covers everything
comment on BPC-157 — 8 things I got wrong before I got it right in c/bpc157 · 107 points · 2 years ago
Short peptides in solution are subject to hydrolysis and, depending on sequence, oxidation. Storage state and time in solution are practical variables that this board almost never discusses.
comment on someone explain 503A to me like I have not read a paper in years in c/compounding · 6 points · 2 years ago
That figure is the starting material purity, not the finished preparation potency. Two different tests.
comment on someone explain 503A to me like I have not read a paper in years in c/compounding · 91 points · 2 years ago
Did they name the facility?
comment on small win: plateau stopped being a problem at week 28 in c/semaglutide · 26 points · 2 years ago
The weekly interval comes out of the half-life — roughly a week — so you are on a smooth curve rather than a series of spikes. That is also why moving your day slightly does very little.
comment on reading pricing threads from 2024 and half of it aged badly in c/glp1uk · 14 points · 2 years ago
Careful, that pricing figure is a headline offer with conditions attached rather than the actual monthly cost.
comment on reading pricing threads from 2024 and half of it aged badly in c/glp1uk · 53 points · 2 years ago
an online consultation that asks you nothing is not a consultation
comment on someone explain 503B to me like I have not read a paper in years in c/compounding · 2 points · 2 years ago
What concentration is on the label, and does it match what you were expecting?
Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.
comment on [Question] Denmark — has anyone got a straight answer on 503B in c/compounding · 76 points · 2 years ago
Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.
comment on [Meta] proposal — a flair for weekly dosing posts in c/semaglutide · 105 points · 2 years ago
Same. I sat at 1.0mg for three months because it was working and there was nothing to fix.
comment on why does nobody talk about semaglutide in c/semaglutide · 2 points · 2 years ago
First month I lost almost nothing and nearly quit.
Adding one thing to this: the appetite effect and the scale run on separate clocks, so both halves can be true at once.
comment on [Discussion] the 503A advice in here is 2 years out of date in c/compounding · 35 points · 2 years ago
I would not read the price difference as a quality signal.
This is the distinction the whole board runs on. Everything else follows from it.
comment on [Discussion] the 503A advice in here is 2 years out of date in c/compounding · 17 points · 2 years ago
the pharmacy and the prescriber are two separate questions